Yoshikazu Yonemitsu,
Professor,
Kyushu University Graduate School of Pharmaceutical Sciences
Professor Yonemitsu graduated in the Faculty of Medicine in 1990, and awarded Ph.D. degree at Kyushu University. He then moved to the National Heart and Lung Institute, Imperial College Collage School of Medicine, London, as a research associate supported by the Wellcome Trust. His expertise in London was the development of highly efficient gene transfer vectors, namely recombinant Sendai virus (rSeV) (Nat Biotechnol, 2000). After going back to Japan, Dr. Yonemitsu started various studies related to translational research, as well as molecular and pathophysiological aspects of atherosclerosis and angiogenesis as an Associate Professor. Then, Professor Yonemitsu got a position at Kyushu University Graduate School of Pharmaceutical Sciences to develop novel gene and cellular therapeutics. His current interest in research is the development of some novel biotherapeutics, including DVC1-0101 as a gene medicine and highly amplified and activated NK-like cell-based cancer adoptive immunotherapy (GAIA-102).
|
|
|